They performed a xenograft tumor growth assay on two different prostate cancer cell lines: LuCaP 86.2, which expresses wild-type androgen receptor (AR) and ARv567, and LuCaP 23.1, which expresses wild-type AR and ARv7. This evidence concerns the gene AR and prostate cancer.